<DOC>
	<DOCNO>NCT00005955</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Chemotherapy combine radiation therapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness temozolomide follow radiation therapy treat child newly diagnose malignant central nervous system tumor .</brief_summary>
	<brief_title>Temozolomide Followed Radiation Therapy Treating Children With Newly Diagnosed Malignant CNS Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate treatment temozolomide child newly diagnose malignant central nervous system tumor . - Determine toxicity treatment patient . - Determine overall survival patient 18 month follow study receive treatment . OUTLINE : Patients stratify accord type disease ( ependymoma v brain stem glioma v malignant glioma v ) . Patients receive oral temozolomide day 1-5 . Treatment repeat every 28 day maximum 4 course absence disease progression unacceptable toxicity . Patients partial complete response may receive additional 8 course temozolomide follow radiotherapy . PROJECTED ACCRUAL : A maximum 100 patient ( 25 per stratum ) accrue study 24-36 month .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm newly diagnose malignant central nervous system tumor require immediate radiotherapy Patients diffuse pontine tumor require histological confirmation Eligible type include follow : Ependymoma Malignant glioma Anaplastic astrocytoma Glioblastoma multiforme Anaplastic oligodendroglioma Gliosarcoma Anaplastic mixed oligoastrocytoma Brainstem glioma Primitive neuroectodermal tumor Nongerminoma germ cell tumor At least one bidimensionally measurable lesion At least 1.5 cm2 within 72 hour surgical resection great 14 day surgery Diffuse pontine tumor require measurable Neurologically stable PATIENT CHARACTERISTICS : Age : 4 21 Performance status : Karnofsky Lansky 70100 % Life expectancy : Greater 12 week Hematopoietic : Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 10 g/dL Hepatic : Bilirubin le 1.5 time upper limit normal ( ULN ) Alkaline phosphatase less 2 time ULN SGOT SGPT less 2.5 time ULN Renal : BUN creatinine less 1.5 time ULN Other : Must able swallow capsule No acute infection treat intravenous antibiotic No nonmalignant systemic disease make patient poor medical risk No frequent vomit medical condition may interfere oral medication intake ( e.g. , partial bowel obstruction ) No prior concurrent malignancy except surgically cure carcinoma situ cervix basal squamous cell carcinoma skin HIV negative Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No one prior biologic therapy regimen No concurrent biologic therapy No concurrent growth factor epoetin alfa Chemotherapy : No one prior chemotherapy regimen No concurrent chemotherapy Endocrine therapy : No increase dos steroid within one week study Radiotherapy : See Disease Characteristics No concurrent radiotherapy Surgery : At least 2 week , great 4 week , since prior surgical resection recover Other : No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>childhood infratentorial ependymoma</keyword>
	<keyword>childhood low-grade cerebral astrocytoma</keyword>
	<keyword>childhood supratentorial ependymoma</keyword>
	<keyword>childhood craniopharyngioma</keyword>
	<keyword>localize resectable neuroblastoma</keyword>
	<keyword>regional neuroblastoma</keyword>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
	<keyword>childhood high-grade cerebral astrocytoma</keyword>
	<keyword>childhood oligodendroglioma</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood grade I meningioma</keyword>
	<keyword>childhood grade II meningioma</keyword>
	<keyword>childhood grade III meningioma</keyword>
	<keyword>untreated childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>untreated childhood cerebellar astrocytoma</keyword>
	<keyword>untreated childhood medulloblastoma</keyword>
	<keyword>untreated childhood visual pathway hypothalamic glioma</keyword>
	<keyword>newly diagnose childhood ependymoma</keyword>
	<keyword>childhood central nervous system choriocarcinoma</keyword>
	<keyword>childhood central nervous system embryonal tumor</keyword>
	<keyword>childhood central nervous system mixed germ cell tumor</keyword>
	<keyword>childhood central nervous system teratoma</keyword>
	<keyword>childhood central nervous system yolk sac tumor</keyword>
</DOC>